Effect of drug efficacy and the eclipse phase of the viral life cycle on estimates of HIV viral dynamic parameters.

Patrick W. Nelson , John E. Mittler , Alan S. Perelson
Journal of Acquired Immune Deficiency Syndromes 26 ( 5) 405 -412

69
2001
Influence of delayed viral production on viral dynamics in HIV-1 infected patients.

John E. Mittler , Bernhard Sulzer , Avidan U. Neumann , Alan S. Perelson
Bellman Prize in Mathematical Biosciences 152 ( 2) 143 -163

239
1998
A model of HIV-1 pathogenesis that includes an intracellular delay.

Patrick W. Nelson , James D. Murray , Alan S. Perelson
Bellman Prize in Mathematical Biosciences 163 ( 2) 201 -215

295
2000
Mathematical analysis of delay differential equation models of HIV-1 infection

Patrick W. Nelson , Alan S. Perelson
Bellman Prize in Mathematical Biosciences 179 ( 1) 73 -94

367
2002
Retention of antigen on follicular dendritic cells and B lymphocytes through complement-mediated multivalent ligand-receptor interactions: theory and application to HIV treatment.

William S. Hlavacek , Jerome K. Percus , Ora E. Percus , Alan S. Perelson
Bellman Prize in Mathematical Biosciences 176 ( 2) 185 -202

27
2002
Current Estimates for HIV-1 Production Imply Rapid Viral Clearance in Lymphoid Tissues

Rob J De Boer , Ruy M Ribeiro , Alan S Perelson ,
PLoS Computational Biology 6 ( 9) e1000906

81
2010
Pharmacodynamics of antiretroviral agents in HIV-1 infected patients: using viral dynamic models that incorporate drug susceptibility and adherence.

Hulin Wu , Yangxin Huang , Edward P. Acosta , Jeong -Gun Park
Journal of Pharmacokinetics and Pharmacodynamics 33 ( 4) 399 -419

32
2006
Viral kinetic modeling: state of the art

Laetitia Canini , Alan S. Perelson
Journal of Pharmacokinetics and Pharmacodynamics 41 ( 5) 431 -443

52
2014
Quantification of Ebola virus replication kinetics in vitro.

Laura E. Liao , Jonathan Carruthers , Sophie J. Smither , Simon A. Weller
PLOS Computational Biology 16 ( 11)

2020
Mathematical modeling of hepatitis C RNA replication, exosome secretion and virus release.

Carolin Zitzmann , Lars Kaderali , Alan S. Perelson
PLOS Computational Biology 16 ( 11)

2020
Models of SIV rebound after treatment interruption that involve multiple reactivation events

Christiaan H. van Dorp , Jessica M. Conway , Dan H. Barouch , James B. Whitney
PLOS Computational Biology 16 ( 10) e1008241

1
2020
Modelling hepatitis C therapy—predicting effects of treatment

Alan S. Perelson , Jeremie Guedj
Nature Reviews Gastroenterology & Hepatology 12 ( 8) 437 -445

54
2015
Recombination Enhances HIV-1 Envelope Diversity by Facilitating the Survival of Latent Genomic Fragments in the Plasma Virus Population

Taina T. Immonen , Jessica M. Conway , Ethan O. Romero-Severson , Alan S. Perelson
PLOS Computational Biology 11 ( 12) e1004625

12
2015
Residual Viremia in Treated HIV+ Individuals

Jessica M. Conway , Alan S. Perelson
PLOS Computational Biology 12 ( 1) e1004677

43
2016
An Overview of Computational and Theoretical Immunology

Alan S. Perelson
international conference on artificial immune systems 439 -441

2004
Effect of 1918 PB1-F2 Expression on Influenza A Virus Infection Kinetics

Amber M. Smith , Frederick R. Adler , Julie L. McAuley , Ryan N. Gutenkunst
PLoS Computational Biology 7 ( 2) e1001081

54
2011
Treatment-Mediated Alterations in HIV Fitness Preserve CD4 + T Cell Counts but Have Minimal Effects on Viral Load

Naveen K. Vaidya , Libin Rong , Vincent C. Marconi , Daniel R. Kuritzkes
PLOS Computational Biology 6 ( 11)

17
2010
Stochastic Theory of Early Viral Infection: Continuous versus Burst Production of Virions

John E. Pearson , Paul Krapivsky , Alan S. Perelson
PLoS Computational Biology 7 ( 2) e1001058

99
2011
Principles Governing Establishment versus Collapse of HIV-1 Cellular Spread.

Jason M. Hataye , Joseph P. Casazza , Katharine Best , C. Jason Liang
Cell Host & Microbe 26 ( 6)

13
2019